Michael Douglas Taylor, Director at Deciphera Pharmaceuticals, Inc. (DCPH), sold 47,784 shares at $46.67 ($2.2M) on 2020-04-17, disclosed to the SEC on 2020-04-21.
Open-market sale of $2.2M DCPH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.67 | 23,892 | $1.1M | 50.0% |
| 2 | $46.67 | 23,892 | $1.1M | 50.0% |
| Total | $46.67 avg | 47,784 | $2.2M | 100% |
| Filing → |
| DCPH | SELL | 2021-03-03 | $655K | — | Filing → |
| DCPH | SELL | 2021-02-03 | $687K | — | Filing → |
| DCPH | SELL | 2021-01-06 | $2.1M | — | Filing → |